| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 137.435 | 148.827 | 128.442 | 131.569 | 179.065 | 123.214 | 88.626 | 181.205 | 339.195 | 259.991 |
| Total Income - EUR | 137.649 | 151.851 | 128.442 | 136.839 | 196.954 | 126.105 | 91.349 | 188.935 | 342.928 | 262.599 |
| Total Expenses - EUR | 130.528 | 145.562 | 94.951 | 132.948 | 153.017 | 106.698 | 90.622 | 151.654 | 164.018 | 208.887 |
| Gross Profit/Loss - EUR | 7.120 | 6.289 | 33.492 | 3.892 | 43.937 | 19.407 | 727 | 37.281 | 178.910 | 53.711 |
| Net Profit/Loss - EUR | 5.524 | 4.718 | 32.154 | 2.568 | 42.062 | 18.173 | 376 | 35.558 | 176.395 | 45.911 |
| Employees | 4 | 4 | 13 | 9 | 9 | 9 | 7 | 8 | 8 | 8 |
Check the financial reports for the company - Bionaticons Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.148 | 1.259 | 3.587 | 9.212 | 3.994 | 11.255 | 8.534 | 13.744 | 21.033 | 33.861 |
| Current Assets | 29.794 | 31.840 | 49.225 | 33.882 | 82.832 | 104.840 | 78.367 | 105.077 | 270.536 | 240.883 |
| Inventories | 11.465 | 17.524 | 0 | 10.560 | 11.149 | 6.652 | 21.226 | 17.059 | 20.017 | 4.208 |
| Receivables | 18.270 | 13.936 | 14.734 | 21.332 | 71.173 | 86.816 | 56.079 | 87.529 | 241.198 | 175.267 |
| Cash | 59 | 380 | 34.490 | 1.990 | 510 | 11.373 | 1.062 | 489 | 9.321 | 61.408 |
| Shareholders Funds | 8.653 | 13.283 | 45.212 | -12.526 | 29.778 | 47.387 | 46.712 | 73.645 | 249.817 | 192.896 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 27.290 | 19.816 | 7.599 | 55.620 | 57.047 | 68.708 | 40.189 | 45.176 | 41.752 | 81.848 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "210 - 210" | |||||||||
| CAEN Financial Year |
210
|
|||||||||
Comments - Bionaticons Srl